Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New Guidelines Shed Light On Private Investment In China Hospitals

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's capital Beijing and Zhejiang Province recently issued long-awaited guidelines to encourage private investment in medical institutions, which is viewed by analysts as a signal that China will implement the policy nationwide and open the gates for private hospitals

You may also be interested in...

China’s Private Hospital Market Takes Flight

Non-public hospitals are blossoming in China, growing at 19% in 2011, and the trend is accelerating, reflected by 20.5% growth in the first five months of 2012.

Insider Analysis From Asia Pacific Bio Intelligence LLC On China State FDA’s Medical Device Regulations

For China’s State FDA, 2011 was a banner year, with regulations released on good manufacturing practices for both drugs and devices. Multinational companies should take notice and be sure their operations are in compliance.

Singapore's Parkway Pantai Sees Luxury Hospital Opportunities In China

SINGAPORE - Parkway Pantai Ltd. CEO Tan See Leng has set his sights on ambitious expansion beyond the company's primary markets in Singapore and Malaysia, including a luxury hospital in China that he equates to the hotel chain Shangri-La Hotels

Related Content

Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts